ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 664217 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 664217; 2) Community: the network communities that were significantly associated with the response to NSC 664217; 3) Molecule: the relationships between components within communities and NSC 664217; 4) MDR: the compounds that were significantly associated with the NSC 664217.

NSC Compound Enrichment Correlation
NSC 746351 Null 0.0137891122538509 0.30604372
NSC 751342 12H-Benzo[g]pyrido[2,1-b]quinazoline-4-carboxamide, N-[2(dimethylamino)ethyl]-12-oxo 0.0137891122538509 0.12306026
NSC 753664 Null 0.0137891122538509 0.38861913
NSC 119915 3-(4,5,6-trihydroxy-3-oxo-3H-xanthen-9-yl)propanoic acid 0.013789112253851 0.14669281
NSC 129794 Ethanesulfonic acid, compd. with 2-chloro-5-[4-[m-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)phenyl]butyl]benzenesulfonyl fluoride (1:1) 0.013789112253851 0.31677276
NSC 244404 Null 0.013789112253851 0.26954533
NSC 275647 5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-.alpha.-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-8-(methoxyacetyl)-, hydrochloride, (8S-cis)- 0.013789112253851 0.29367671
NSC 300289 Pinafide 0.013789112253851 0.028341415
NSC 303861 L-Cysteine analog 0.013789112253851 0.48457315
NSC 328410 Camptothecin Derivative 0.013789112253851 0.046436713
Total:121  Current:55    [First] [Prev] [Next] [Last]